
    
      The study will be placed in 6 rheumatology clinics in Switzerland and in 4 travel medicine
      clinics. Consecutive subjects with rheumatoid arthritis, spondylarthritis (ankylosing
      spondylitis), vasculitis (ANCA associated vasculitis and Beh√ßet's disease) and healthy
      controls will be recruited.
    
  